In this interview we discuss outcomes in clinical trials and how to improve trials by redefining clinically meaningful outcomes.
David M. Dilts, PhD
Advertisement
Articles by David M. Dilts, PhD
Advertisement
Latest Updated Articles
Improving Cancer Clinical TrialsPublished: May 15th 2014 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Tarlatamab Plus Chemo/IO Regimens Are Safe, Elicit Responses in ES-SCLC
2
Pembrolizumab Combo Significantly Improves PFS/OS in Recurrent PROC
3
Sacituzumab Tirumotecan Improves Survival in Second-Line EGFR+ NSCLC
4
Adjuvant Therapy Confers Postoperative ctDNA Clearance, DFS Benefit in CRC
5
